                </a></li></ul></div><p><strong>Figure 6.  <span>Major changes after 16-months after activation of hVEGF-A<sub>165</sub> expression.</span></strong></p><a id="article1.body1.sec2.sec2.fig2.caption1.p1" name="article1.body1.sec2.sec2.fig2.caption1.p1"></a><p>A. Liver: Encapsulated hepatocellular carcinoma was highly necrotic and focally calcified (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p2" name="article1.body1.sec2.sec2.fig2.caption1.p2"></a><p>B. Lung: Papillary adenocarcinoma. (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p3" name="article1.body1.sec2.sec2.fig2.caption1.p3"></a><p>C. Macroscopical changes in liver (box shows the area of the microscopical sections in F–H).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p4" name="article1.body1.sec2.sec2.fig2.caption1.p4"></a><p>D. Macroscopical changes in spleen, control spleen on the left (microscopical sections in I–K).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p5" name="article1.body1.sec2.sec2.fig2.caption1.p5"></a><p>E. Macroscopical changes in paratubarian area (microscopical sections in L–N).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p6" name="article1.body1.sec2.sec2.fig2.caption1.p6"></a><p>F. Cavernous hemangioma featuring focal hyalinization.</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p7" name="article1.body1.sec2.sec2.fig2.caption1.p7"></a><p>G. The same tumor mass area with higher magnification (haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p8" name="article1.body1.sec2.sec2.fig2.caption1.p8"></a><p>H. Weak focal hVEGF-A<sub>165</sub> immunoreactivity was present in the same area (True Blue as a chromogen), arrows indicate positive cells.</p>
